Apotex Corp Recalls Birth Control Pill Over Defective Packaging
John Curiel2 weeks ago
In coordination with the FDA, Canadian pharmaceutical company Apotex Corp. has recalled four lots of Drospirenone and Ethinyl Estradiol Tablets, USP. Drospirenone and Ethinyl Estradiol is an estrogen/progesterone contraceptive.
Information About the Birth Control Recall
According to WAFB9, the drug may contain defective blisters and incorrect tablet placement, while the package may be missing some tablets altogether.
Women who try taking the affected birth control pills might accidentally take a placebo instead of an active tablet, or the appropriate tablet could be missing. Taking birth control pills the wrong way could lead to unplanned pregnancy and other health complications.
Currently, there are no reports of unplanned pregnancy attributed to the affected pills.
FDA Urges Women to Consult Pharmacy and Healthcare Provider
The FDA urges women to return the affected pills to their local pharmacy and consult with their physician about possible alternatives.
The following lots are part of the recall:
The package contains 21 active yellow tablets and seven placebo tablets.
Contact an Experienced Dangerous Drug Attorney
If you or a loved one has been the victim of a dangerous pharmaceutical drug or medical device, you may be entitled to compensation. You deserve dynamic representation from a law firm with the resources necessary to take on the pharmaceutical companies. Thomas J. Henry has a track record of helping clients receive record-breaking verdicts, settlements, and judgments.